Skip to main content
Erschienen in: Supportive Care in Cancer 7/2018

04.02.2018 | Original Article

Rural versus urban differences in end-of-life care for lung cancer patients in Germany

verfasst von: Julia Walter, Amanda Tufman, Reiner Leidl, Rolf Holle, Larissa Schwarzkopf

Erschienen in: Supportive Care in Cancer | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess rural-urban differences in healthcare utilization and supportive care at the end-of-life in German lung cancer patients.

Methods

We identified 12,929 patients with incident lung cancer in 2009 from claims data and categorized them to four district types (major city, urban, rural, remote rural). We compared site of death, unplanned hospitalizations, hospital days, outpatient doctor, general practitioner (GP) and home visits, structured palliative care, therapy with antidepressants, pain relief medication and chemotherapy, and therapeutic puncturing in the last 30 and 14 days of life using mixed models with logistic link function for binary outcomes and log link function for count data. We adjusted all models by age, sex, comorbidities, metastases location and presence of multiple tumors at diagnosis, survival in months, and type of tumor-directed treatment.

Results

We found significant differences in two of the outcomes measured. The likelihood of > 14 hospital days in the last 30 days was significantly higher in rural districts than in remote rural districts (1.27 [1.05, 1.52], p = 0.0003). The number of visits to the GP in the last 30 days of life was significantly lower in urban districts than in remote rural districts (β = − 0.19 [− 0.32, − 0.06], p = <0.0001). No other endpoints were associated with regional differences. Triggering factors for high and low utilization of healthcare were mostly age, comorbidities, and prior anticancer treatment.

Conclusion

Healthcare utilization and supportive care did not differ significantly between different district types. Results reject the hypothesis of regional inequity in end-of-life care of lung cancer patients in Germany.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Robert K, Institut: Krebs in Deutschland 2011/2012. In.; 2012 Robert K, Institut: Krebs in Deutschland 2011/2012. In.; 2012
3.
Zurück zum Zitat Steele CB, Pisu M, Richardson LC (2011) Urban/rural patterns in receipt of treatment for non-small cell lung cancer among black and white Medicare beneficiaries, 2000-2003. J Natl Med Assoc 103(8):711–718CrossRefPubMed Steele CB, Pisu M, Richardson LC (2011) Urban/rural patterns in receipt of treatment for non-small cell lung cancer among black and white Medicare beneficiaries, 2000-2003. J Natl Med Assoc 103(8):711–718CrossRefPubMed
5.
Zurück zum Zitat Thomas AA, Pearce A, O’Neill C, Molcho M, Sharp L (2016) Urban-rural differences in cancer-directed surgery and survival of patients with non-small cell lung cancer. J Epidemiol Community Health Thomas AA, Pearce A, O’Neill C, Molcho M, Sharp L (2016) Urban-rural differences in cancer-directed surgery and survival of patients with non-small cell lung cancer. J Epidemiol Community Health
6.
Zurück zum Zitat Baird G, Flynn R, Baxter G, Donnelly M, Lawrence J (2008) Travel time and cancer care: an example of the inverse care law? Rural Remote Health 8(4):1003PubMed Baird G, Flynn R, Baxter G, Donnelly M, Lawrence J (2008) Travel time and cancer care: an example of the inverse care law? Rural Remote Health 8(4):1003PubMed
7.
Zurück zum Zitat Lin CC, Bruinooge SS, Kirkwood MK, Hershman DL, Jemal A, Guadagnolo BA, Yu JB, Hopkins S, Goldstein M, Bajorin D, Giordano SH, Kosty M, Arnone A, Hanley A, Stevens S, Olsen C (2016) Association between geographic access to cancer care and receipt of radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 94(4):719–728. https://doi.org/10.1016/j.ijrobp.2015.12.012 CrossRefPubMed Lin CC, Bruinooge SS, Kirkwood MK, Hershman DL, Jemal A, Guadagnolo BA, Yu JB, Hopkins S, Goldstein M, Bajorin D, Giordano SH, Kosty M, Arnone A, Hanley A, Stevens S, Olsen C (2016) Association between geographic access to cancer care and receipt of radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 94(4):719–728. https://​doi.​org/​10.​1016/​j.​ijrobp.​2015.​12.​012 CrossRefPubMed
10.
Zurück zum Zitat Kirby S, Barlow V, Saurman E, Lyle D, Passey M, Currow D (2016) Are rural and remote patients, families and caregivers needs in life-limiting illness different from those of urban dwellers? A narrative synthesis of the evidence. Aust J Rural Health 24(5):289–299. https://doi.org/10.1111/ajr.12312 CrossRefPubMed Kirby S, Barlow V, Saurman E, Lyle D, Passey M, Currow D (2016) Are rural and remote patients, families and caregivers needs in life-limiting illness different from those of urban dwellers? A narrative synthesis of the evidence. Aust J Rural Health 24(5):289–299. https://​doi.​org/​10.​1111/​ajr.​12312 CrossRefPubMed
11.
Zurück zum Zitat Goeckenjan G, Sitter H, Thomas M, Branscheid D, Flentje M, Griesinger F, Niederle N, Stuschke M, Blum T, Deppermann KM et al (2010) Prevention, diagnosis, therapy, and follow-up of lung cancer. Pneumologie 64(Suppl 2):e1–164CrossRefPubMed Goeckenjan G, Sitter H, Thomas M, Branscheid D, Flentje M, Griesinger F, Niederle N, Stuschke M, Blum T, Deppermann KM et al (2010) Prevention, diagnosis, therapy, and follow-up of lung cancer. Pneumologie 64(Suppl 2):e1–164CrossRefPubMed
16.
Zurück zum Zitat Nayar P, Qiu F, Watanabe-Galloway S, Boilesen E, Wang H, Lander L, Islam M (2014) Disparities in end of life care for elderly lung cancer patients. J Community Health 39(5):1012–1019CrossRefPubMed Nayar P, Qiu F, Watanabe-Galloway S, Boilesen E, Wang H, Lander L, Islam M (2014) Disparities in end of life care for elderly lung cancer patients. J Community Health 39(5):1012–1019CrossRefPubMed
20.
Zurück zum Zitat Sano M, Fushimi K (2016) Association of palliative care consultation with reducing inpatient chemotherapy use in elderly patients with cancer in Japan: analysis using a Nationwide administrative database. Am J Hosp Palliat Care Sano M, Fushimi K (2016) Association of palliative care consultation with reducing inpatient chemotherapy use in elderly patients with cancer in Japan: analysis using a Nationwide administrative database. Am J Hosp Palliat Care
22.
Zurück zum Zitat Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, Ferrell BR, Loscalzo M, Meier DE, Paice JA, Peppercorn JM, Somerfield M, Stovall E, von Roenn JH (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30(8):880–887. https://doi.org/10.1200/JCO.2011.38.5161 CrossRefPubMed Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, Ferrell BR, Loscalzo M, Meier DE, Paice JA, Peppercorn JM, Somerfield M, Stovall E, von Roenn JH (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30(8):880–887. https://​doi.​org/​10.​1200/​JCO.​2011.​38.​5161 CrossRefPubMed
23.
Zurück zum Zitat Islam KM, Jiang X, Anggondowati T, Lin G, Ganti AK (2015) Comorbidity and survival in lung cancer patients. Cancer Epidemiol Biomark Prev 24(7):1079–1085CrossRef Islam KM, Jiang X, Anggondowati T, Lin G, Ganti AK (2015) Comorbidity and survival in lung cancer patients. Cancer Epidemiol Biomark Prev 24(7):1079–1085CrossRef
25.
Zurück zum Zitat Nennecke A, Brenner H, Eberle A, Geiss K, Holleczek B, Kieschke J, Kraywinkel K (2010) Cancer survival analysis in Germany—heading towards representative and comparable findings. Gesundheitswesen 72(10):692–699CrossRefPubMed Nennecke A, Brenner H, Eberle A, Geiss K, Holleczek B, Kieschke J, Kraywinkel K (2010) Cancer survival analysis in Germany—heading towards representative and comparable findings. Gesundheitswesen 72(10):692–699CrossRefPubMed
29.
Zurück zum Zitat Roscoe LA, Schonwetter RS (2006) Improving access to hospice and palliative care for patients near the end of life: present status and future direction. J Palliat Care 22(1):46–50PubMed Roscoe LA, Schonwetter RS (2006) Improving access to hospice and palliative care for patients near the end of life: present status and future direction. J Palliat Care 22(1):46–50PubMed
31.
Zurück zum Zitat Lutfiyya MN, Bhat DK, Gandhi SR, Nguyen C, Weidenbacher-Hoper VL, Lipsky MS (2007) A comparison of quality of care indicators in urban acute care hospitals and rural critical access hospitals in the United States. Int J Qual Health Care 19(3):141–149. https://doi.org/10.1093/intqhc/mzm010 CrossRef Lutfiyya MN, Bhat DK, Gandhi SR, Nguyen C, Weidenbacher-Hoper VL, Lipsky MS (2007) A comparison of quality of care indicators in urban acute care hospitals and rural critical access hospitals in the United States. Int J Qual Health Care 19(3):141–149. https://​doi.​org/​10.​1093/​intqhc/​mzm010 CrossRef
32.
Zurück zum Zitat Räbiger J, Woskanjan S: Wo werden Krebskranke besser versort? Ein Forschungsprojekt vergleicht die medizinisch-pflegerische Versorgung onkologischer patienten im städtischen und ländlichen Raum. alice 2015, 29 Räbiger J, Woskanjan S: Wo werden Krebskranke besser versort? Ein Forschungsprojekt vergleicht die medizinisch-pflegerische Versorgung onkologischer patienten im städtischen und ländlichen Raum. alice 2015, 29
Metadaten
Titel
Rural versus urban differences in end-of-life care for lung cancer patients in Germany
verfasst von
Julia Walter
Amanda Tufman
Reiner Leidl
Rolf Holle
Larissa Schwarzkopf
Publikationsdatum
04.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 7/2018
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4063-y

Weitere Artikel der Ausgabe 7/2018

Supportive Care in Cancer 7/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.